Raymond James & Associates’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,468
| Closed | -$281K | – | 4075 |
|
|
2022
Q1 | $281K | Buy |
10,468
+1,598
| +18% | +$42.9K | ﹤0.01% | 3430 |
|
|
2021
Q4 | $423K | Sell |
8,870
-1,128
| -11% | -$53.8K | ﹤0.01% | 3196 |
|
|
2021
Q3 | $664K | Sell |
9,998
-363
| -4% | -$24.1K | ﹤0.01% | 2851 |
|
|
2021
Q2 | $808K | Sell |
10,361
-90
| -0.9% | -$7.02K | ﹤0.01% | 2726 |
|
|
2021
Q1 | $989K | Sell |
10,451
-131
| -1% | -$12.4K | ﹤0.01% | 2518 |
|
|
2020
Q4 | $1.29M | Sell |
10,582
-484
| -4% | -$59K | ﹤0.01% | 2162 |
|
|
2020
Q3 | $967K | Sell |
11,066
-266
| -2% | -$23.2K | ﹤0.01% | 2194 |
|
|
2020
Q2 | $732K | Buy |
+11,332
| New | +$732K | ﹤0.01% | 2343 |
|